Latest on Human Papilloma Virus Vaccine for Cervical Cancer
/
RSS Feed
John Schiller
John Schiller, National Cancer Institute, Bethesda
The human papilloma virus vaccine, which is currently being tested in the prevention of cervical cancer, brings together both infectious disease and cancer. Delegates at the ICAAC conference heard an update on both the anti-cancer and the anti-wart activities of the two vaccines: one from Merck and the other from GlaxoSmithKline.
[audio:https://www.audiomedica.com/podcasting/icaac2005/john_schiller.mp3]
You may also like...
Avoiding A Silent Killer: Simple Blood And Urine Test To Detect Early Kidney Disease 14 Aug, 2010 - New Research Questions Statin ‘Benefit’ In People At Low Risk Of Heart Disease 27 Jan, 2011
- Women Just As Likely As Men To Have Tuberculosis 16 Feb, 2010
- Research Finds HIV/AIDS Discordant Couples Face Stigma 2 Jan, 2012
